Search results
23 hours ago · Atypical Squamous Cells of Undetermined Significance (ASC-US) This is the most common abnormal Pap smear result. It means some cells in the cervix don’t look normal, but the reason isn’t clear. It could be due to HPV, irritation, infection, or changes during pregnancy or menopause. Low-Grade Squamous Intraepithelial Lesions (LSIL)
People also ask
What is atypical squamous epithelium?
What is primary squamous cell carcinoma (SCC) and atypical fibroxanthoma (AFX)?
What is atypical fibroxanthoma (AFX)?
Sep 2, 2024 · An abnormal Pap smear result doesn’t automatically mean you have cancer. It simply means that some of the cells collected from your cervix appear unusual. Abnormal results can range from mild to severe and are categorized into different grades: ASC-US (Atypical Squamous Cells of Undetermined Significance): This result means that the cells are ...
Aug 19, 2024 · Of the 49 low-grade squamous intraepithelial lesion or higher that were designed by AICyte as not needing further review, the cytohistologic correlation revealed eight cases of cervical intraepithelial neoplasia 1 and 18 negative cases; and the remaining cases were without histologic follow-up.
Sep 6, 2024 · Dysplasia is the growth of abnormal cells within tissues or organs. This can happen in any part of the body. You might hear the term "cervical dysplasia" following a Pap test. Or "hip dysplasia" following imaging tests on an infant or young child. Dysplasia isn't cancer.
Aug 27, 2024 · Some cases may represent primary squamous cell carcinoma (SCC) that fails to express keratin. Atypical fibroxanthoma (AFX) is a tumor that occurs primarily in older individuals after the...
Aug 22, 2024 · For atypical squamous cells of undetermined significance (ASC-US) and ASC-H cases, 23 (56.1%) were in the top 50%, and 39 (95.1%) were in the top 75%.
Aug 31, 2024 · Cutaneous squamous cell carcinoma (cSCC) comprises 20% of cases of nonmelanoma skin cancers in the United States. In total, 3% to 5% of squamous cell carcinoma (SCC) are metastatic at the time of presentation, associated with significant mortality due to a lack of standardized treatment options.
